Sentence examples for microarray technologies such from inspiring English sources

We have also provided alpha and beta testing services to companies that are introducing new microarray technologies, such as novel detection systems and data-analysis tools.

Novel microarray technologies such as the AB1700 platform from Applied Biosystems promise significant increases in the signal dynamic range and a higher sensitivity for weakly expressed transcripts.

Microarray technologies such as the Affymetrix Genechip® platform facilitate rapid measurement of the expression levels of thousands of transcripts in a single experiment and allow comparison of expression patterns across many samples [ 8].

The development of microarray technologies, such as array comparative genomic hybridization (array-CGH) and whole-genome SNP genotyping technologies, has enhanced the study of human SVs at the genome-wide level by detecting gains and losses of DNA regions compared to the reference genome [ 12- 14].

The chapter outlines the human neurological diseases studied by microarray technology, such as multiple sclerosis, brain tumors, neuromuscular disorders, and alzheimer's disease.

In the early years of microarray technology, such an application could be possible; however, in practice, the expressional changes are often confirmed by other methods or by a different level of observations such as enzymatic activities, even in such experiments.

Other microarray-based technologies, such as comparative genomic hybridisation that provides a genome-wide survey of copy number changes, have also been utilised to study relationship between surgical outcome and biological factors.

Although XSpecies results have less power than a regular microarray experiment and technologies such as RNAseq performed by Next Generation Sequencing (NGS), the technique was able to identify important genes related to metabolic processes involved in papaya ripening.

These probes can be used by reference laboratories or even by the largest diagnostic laboratories, in multiplexed amplification or DNA microarray technologies, for identification of such 'high risk' resistant clones involved in hospital or community outbreaks.

New technologies such as microarray comparative genomic hybridization, also termed chromosomal microarray (CMA), enable a more precise assessment of chromosomal structure and have thus been proposed to be useful for prenatal diagnosis [ 1].

In addition to custom designed isoform-sensitive microarrays [ 29], commercial technologies such as the Affymetrix GeneChip Human Exon 1.0 Array have made research in these areas more accessible.